180 Life Sciences - Warrants (07/11/2025) (ATNFW) has a profit margin of -18427.17%, below the Healthcare sector average of 13.89%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
The latest profit margin for ATNFW is -18427.17% as of June 2026. That is below the Healthcare sector average of 13.89%. Investors often review this figure alongside 180 Life Sciences - Warrants (07/11/2025)'s historical trend and sector peers before judging valuation or financial health.
Against Healthcare companies, ATNFW currently prints -18427.17% for profit margin, while the sector average sits near 13.89%. That is roughly 132735.7% below the sector mean. Large gaps often invite a closer look at 180 Life Sciences - Warrants (07/11/2025)'s growth, margins, and balance sheet.
Profit Margin shows how effectively 180 Life Sciences - Warrants (07/11/2025) converts resources into returns. At -18427.17%, ATNFW may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting ATNFW's profit margin (-18427.17%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack 180 Life Sciences - Warrants (07/11/2025)'s profit margin against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.